← Leaderboards
Emily Colleen Erickson
Harvard Medical School
$66,970
Attributed
$66,970
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $33.7K · FY2020–21$50K$37.5K$25K$12.5K$0
'20
'21
Funding mix
By agency
NIH$66,970 · 1
By mechanism
F31$66,970 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Priscilla Li-Ning Yang$20,185,658
- Leon Peshkin$6,585,278
- Marc W Kirschner$55,400,682
- Steven P Gygi$23,279,525
- Aedin C Culhane$2,653,443
Others in their field
Other Emerging Leaders on “Akt Inhibition”
- Sana D Karam · University Of Colorado Denver$4,039,397
- David C Fajgenbaum · University Of Pennsylvania$3,156,612
- Claudio Scafoglio · University Of California Los Angeles$2,825,956
- Triparna Sen · Sloan-Kettering Inst Can Research$2,439,200
- Rachel A Gottschalk · University Of Pittsburgh At Pittsburgh$2,312,731
- Tony Yuen · Icahn School Of Medicine At Mount Sinai$2,104,363
Research focus
Akt InhibitionAutomobile DrivingBaseBiologicalBiological MarkersBiological ProcessBreast Cancer CellCancer Cell GrowthCancer InterventionCell DeathCell GrowthCell KillingCell PhysiologyCell SurvivalChemical ConjugateClinical EfficacyClinical InvestigationClinical TrialsClustered Regularly Interspaced Short Palindromic RepeatsDose-LimitingDrug KineticsEpigenetic MarkerExhibitsAcute